Benjamin L Palleiko - Net Worth and Insider Trading
Benjamin L Palleiko Net Worth
The estimated net worth of Benjamin L Palleiko is at least $2 Million dollars as of 2024-05-29. Benjamin L Palleiko is the CHIEF EXECUTIVE OFFICER of KalVista Pharmaceuticals Inc and owns about 216,387 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $2 Million. Details can be seen in Benjamin L Palleiko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benjamin L Palleiko has not made any transactions after 2024-05-20 and currently still holds the listed stock(s).
Transaction Summary of Benjamin L Palleiko
Benjamin L Palleiko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin L Palleiko owns 2 companies in total, including KalVista Pharmaceuticals Inc (KALV) , and Ore Holdings Inc (ORXE) .
Click here to see the complete history of Benjamin L Palleiko’s form 4 insider trades.
Insider Ownership Summary of Benjamin L Palleiko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-05-20 | CFO and Secretary |
| ORXE | Ore Holdings Inc | 2010-01-18 | SVP & Chief Financial Officer |
Benjamin L Palleiko Latest Holdings Summary
Benjamin L Palleiko currently owns a total of 1 stock. Benjamin L Palleiko owns 216,387 shares of KalVista Pharmaceuticals Inc (KALV) as of May 20, 2024, with a value of $2 Million.
Latest Holdings of Benjamin L Palleiko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-05-20 | 216,387 | 11.08 | 2,397,568 |
Holding Weightings of Benjamin L Palleiko
Benjamin L Palleiko Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin L Palleiko has made a total of 11 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 21,959 shares on May 20, 2024, which brought Benjamin L Palleiko around $258,238.
Insider Trading History of Benjamin L Palleiko
- 1
Benjamin L Palleiko Trading Performance
Benjamin L Palleiko Ownership Network
Benjamin L Palleiko Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Benjamin L Palleiko is the CFO and Secretary of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , Chief Development Officer Christopher Yea , and Chief Scientific Officer Edward P. Feener .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Benjamin L Palleiko made 7 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 120,682. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 118,495 shares made by Edward P. Feener , and a net sale of 165,254 shares made by Thomas Andrew Crockett .
In summary, during the past 3 months, insiders sold 54,832 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 54,832 shares. During the past 18 months, 555,233 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 695,784 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Benjamin L Palleiko Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin L Palleiko. You might contact Benjamin L Palleiko via mailing address: C/o Kalvista Pharmaceuticals, Inc., One Kendall Square, Bld 200, Ste 2203, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
